AAAAAA
Results: 1-25/29
Authors:
Li, N
van Agthoven, M
Willemse, PHB
Uyl-de Groot, CA
Citation: N. Li et al., A cost-utility analysis comparing second-line chemotherapy schemes in patients with metastatic breast cancer, ANTI-CANC D, 12(6), 2001, pp. 533-540
Authors:
Duffaud, F
van der Burg, MEL
Namer, M
Vergote, I
Willemse, PHB
Huinink, WT
Guastalla, JP
Nooij, MA
Kerbrat, P
Piccart, M
Tumolo, S
Favalli, G
van der Vange, N
Lacave, AJ
Wils, J
Splinter, TAW
Einhorn, N
Roozendaal, KJ
Rosso, R
Vermorken, JB
Citation: F. Duffaud et al., D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTCgynaecological cancer co-operative group study, ANTI-CANC D, 12(2), 2001, pp. 159-162
Authors:
Esajas, MD
Duk, JM
de Bruijn, HWA
Aalders, JG
Willemse, PHB
Sluiter, W
Pras, B
ten Hoor, K
Hollema, H
van der Zee, AGJ
Citation: Md. Esajas et al., Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer, J CL ONCOL, 19(19), 2001, pp. 3960-3966
Authors:
Bos, AME
van der Graaf, WTA
Willemse, PHB
Citation: Ame. Bos et al., A new conservative approach to extravasation of anthracyclines with dimethylsulfoxide and dexrazoxane, ACTA ONCOL, 40(4), 2001, pp. 541-542
Authors:
Nieboer, P
de Vries, EGE
Mulder, NH
Sleijfer, DT
Willemse, PHB
Hospers, GAP
Gietema, JA
Sluiter, WJ
van der Graaf, WTA
Citation: P. Nieboer et al., Long-term haematological recovery following high-dose chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation in patients with solid tumours, BONE MAR TR, 27(9), 2001, pp. 959-966
Authors:
Nieboer, P
Mulder, NH
Van Der Graaf, WTA
Willemse, PHB
Hospers, GAP
Citation: P. Nieboer et al., Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma, ANTICANC R, 21(4B), 2001, pp. 3115-3116
Authors:
Mourits, MJE
De Vries, EGE
Willemse, PHB
Ten Hoor, KA
Hollema, H
Van der Zee, AGJ
Citation: Mje. Mourits et al., Tamoxifen treatment and gynecologic side effects: A review, OBSTET GYN, 97(5), 2001, pp. 855-866
Authors:
Kema, IP
Meijer, WG
Meiborg, G
Ooms, B
Willemse, PHB
de Vries, EGE
Citation: Ip. Kema et al., Profiling of tryptophan-related plasma indoles in patients with carcinoid tumors by automated, on-line, solid-phase extraction and HPLC with fluorescence detection, CLIN CHEM, 47(10), 2001, pp. 1811-1820
Authors:
Sonneveld, DJA
Hoekstra, HJ
van der Graaf, WT
Sluiter, WJ
Mulder, NH
Willemse, PHB
Koops, HS
Sleijfer, DT
Citation: Dja. Sonneveld et al., Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era, CANCER, 91(7), 2001, pp. 1304-1315
Authors:
Freue, M
Kjaer, M
Boni, C
Joliver, J
Janicke, F
Willemse, PHB
Coombes, RC
Van Belle, S
Perez-Carrion, R
Zieschang, J
de Palacios, PI
Rose, C
Citation: M. Freue et al., Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen, BREAST, 9(1), 2000, pp. 9-16
Authors:
Hofstra, LS
de Vries, EGE
Mulder, NH
Willemse, PHB
Citation: Ls. Hofstra et al., Intraperitoneal chemotherapy in ovarian cancer, CANC TR REV, 26(2), 2000, pp. 133-143
Authors:
Rodenburg, CJ
Willemse, PHB
Mulder, NH
Citation: Cj. Rodenburg et al., Consensus conference on adjuvant and palliative treatment of colorectal cancer, NETH J MED, 57(2), 2000, pp. 50-57
Authors:
Jager, PL
Meijer, WG
Kema, IP
Willemse, PHB
Piers, DA
de Vries, EGE
Citation: Pl. Jager et al., L-3-[I-123]iodo-alpha-methyltyrosine scintigraphy in carcinoid tumors: Correlation with biochemical activity and comparison with [In-111-DTPA-D-Phe(1)]-octreotide imaging, J NUCL MED, 41(11), 2000, pp. 1793-1800
Authors:
Mourits, MJE
van der Zee, AGJ
Willemse, PHB
de Vries, EGE
Citation: Mje. Mourits et al., The ovary: cysts, screening, and tamoxifen, LANCET, 355(9220), 2000, pp. 2078-2079
Authors:
Engelen, MJA
de Bruijn, HWA
Hollema, H
ten Koor, KA
Willemse, PHB
Aalders, JG
van der Zee, AGJ
Citation: Mja. Engelen et al., Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors, GYNECOL ONC, 78(1), 2000, pp. 16-20
Authors:
Meijer, WG
Kema, IP
Volmer, M
Willemse, PHB
De Vries, EGE
Citation: Wg. Meijer et al., Discriminating capacity of indole markers in the diagnosis of carcinoid tumors, CLIN CHEM, 46(10), 2000, pp. 1588-1596
Authors:
Bos, AME
de Graaf, H
de Vries, EGE
Piersma, H
Willemse, PHB
Citation: Ame. Bos et al., Feasibility of a dose-intensive CMF regimen with granulocyte colony-stimulating factor as adjuvant therapy in premenopausal patients with node-positive breast cancer, BR J CANC, 82(12), 2000, pp. 1920-1924
Authors:
Arts, HJG
Katsaros, D
de Vries, EGE
Massobrio, M
Genta, F
Danese, S
Arisio, R
Scheper, RJ
Kool, M
Scheffer, GL
Willemse, PHB
van der Zee, AGJ
Suurmeijer, AJH
Citation: Hjg. Arts et al., Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma, CLIN CANC R, 5(10), 1999, pp. 2798-2805
Authors:
Berek, JS
Bertelsen, K
du Bois, A
Brady, MF
Carmichael, J
Eisenhauer, EA
Gore, M
Grenman, S
Hamilton, TC
Hansen, SW
Harper, PG
Horvath, G
Kaye, SB
Luck, HJ
Lund, B
McGuire, WP
Neijt, JP
Ozols, RF
Parmar, MKB
Piccart-Gebhart, MJ
van Rijswijk, R
Rosenberg, P
Rustin, GJS
Sessa, C
Thigpen, JT
Trope, C
Tuxen, MK
Vergote, I
Vermorken, JB
Willemse, PHB
Citation: Js. Berek et al., Advanced epithelial ovarian cancer: 1998 consensus statements, ANN ONCOL, 10, 1999, pp. 87-92
Authors:
Schroder, CP
de Vries, EGE
Muder, NH
Willemse, PHB
Sleijfer, DT
Hospers, GAP
van der Graaf, WTA
Citation: Cp. Schroder et al., Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B, J ANTIMICRO, 43(5), 1999, pp. 741-743
Authors:
Hofstra, LS
Mourits, MJE
De Vries, EGE
Mulder, NH
Willemse, PHB
Citation: Ls. Hofstra et al., Combined treatment with goserelin and tamoxifen in patients with advanced chemotherapy resistant ovarian cancer, ANTICANC R, 19(4C), 1999, pp. 3627-3630
Authors:
Mourits, MJE
Van der Zee, AGJ
Willemse, PHB
Ten Hoor, KA
Hollema, H
De Vries, EGE
Citation: Mje. Mourits et al., Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen, GYNECOL ONC, 73(1), 1999, pp. 21-26
Authors:
Kema, IP
Willemse, PHB
de Vries, EGE
Citation: Ip. Kema et al., Carcinoid tumors, N ENG J MED, 341(6), 1999, pp. 453-454
Authors:
Arts, HJG
Hollema, H
Lemstra, W
Willemse, PHB
De Vries, EGE
Kampinga, HH
Van der Zee, AGJ
Citation: Hjg. Arts et al., Heat-shock-protein-27(HSP27) expression in ovarian carcinoma: Relation in response to chemotherapy and prognosis, INT J CANC, 84(3), 1999, pp. 234-238
Authors:
Meijer, WG
Swaanenburg, JCJM
van Veldhuisen, D
Kema, IP
Willemse, PHB
de Vries, EGE
Citation: Wg. Meijer et al., Troponin I, troponin T, and creatine kinase-MB mass in patients with the carcinoid syndrome with and without heart failure, CLIN CHEM, 45(12), 1999, pp. 2296-2297